Seres Therapeutics, Inc. (MCRB) Revenue 2016–2025
Seres Therapeutics, Inc. (MCRB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$789,000FY2025 · since FY2016: $21.8M → $789,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $789,000 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $7.1M | -95.0% |
| FY2021 | $143.9M | +1109.2% |
| FY2020 | $11.9M | -56.2% |
| FY2019 | $27.2M | +1.0% |
| FY2018 | $26.9M | -16.1% |
| FY2017 | $32.1M | +47.5% |
| FY2016 | $21.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice